AstraZeneca gets a US high
95%FTSE 100 drug firm AstraZeneca (AZN) is to launch a once-daily oral treatment for sufferers of type 2 diabetes in the USA after receiving clearance for its sale (13 Jan) from regulator the Food & Drug Administration...
16 January 2014
